Having the president's seal of approval on any of those was
Having the president's seal of approval on any of those was a golden ticket for them... for a little while. They just had the Golden ticket to the wrong destination. Those votes of support given by Trump were never given randomly and were based on at least something said by a doctor.
Trump needs votes and he wants LL in the worst way. However, with a list of 400 different treatments out there he is working his way down the list. We aren't the first, the second, or the third... but we ARE on the list. He'll get there.
Yes, Trump has failed, in many ways in my opinion, but... there are supporters of his, and many of them, that will do anything he says. He mentions LL, there will be a supporter who stockpiles a million doses of it in West Virginia somewhere (sorry if you are from West Virginia too). Hell... People injected the Clorox stuff... Just like he said to.
There may be some benefit to some of the other treatments that Trump suggested but you are right... Not enough. LL is it and all of us will be happy with a mention.
2
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...
Continue Reading
Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...
Continue Reading
AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...
Continue Reading
Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...
Continue Reading
Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...
Continue Reading
Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...
Continue Reading
Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...
Continue Reading
Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...
Continue Reading
Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....
Continue Reading
Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...
Continue Reading
Top 5 Most Recently Viewed Articles
America's Car-Mart Under Investor Scrutiny Recently, America's Car-Mart, Inc. (NASDAQ: CRMT) experienced a noteworthy stock decline as investors reacted to disappointing Q1 2026 financial results. The significant drop of over $8, approximately 18%, raised concerns among shareholders and prompted investigation into the company's operational strategies concerning tariff...
Continue Reading
Lands' End Achieves Significant Financial Milestones DODGEVILLE, Wis. – Lands’ End, Inc. (NASDAQ: LE) has announced its financial results for the fourth quarter and the entire fiscal year 2024, which concluded recently. This announcement follows a year characterized by steady growth and strategic innovation. Strong Performance in the Fourth Quarter During the fourth...
Continue Reading
Wegovy® Demonstrates Hepatic Benefits Beyond Weight Loss Novo Nordisk has recently unveiled intriguing findings regarding Wegovy® (semaglutide 2.4 mg) that highlight its role in enhancing liver health in adults diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), even in the context of limited weight loss. This revelation emerged from a post hoc...
Continue Reading
Measurabl Introduces Free Sustainability Software Measurabl, renowned for its sustainability data platform in real estate, has unveiled a groundbreaking free software solution. This innovative tool allows property and portfolio managers to measure, manage, and report on sustainability performance without any cost. With this recent launch, Measurabl has already registered...
Continue Reading
The Joint Corp. Showcases Remarkable Growth in 2024 Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for Majority of Corporate Portfolio - SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's...
Continue Reading